[HTML][HTML] Proteomics technologies for cancer liquid biopsies
Alterations in DNAs could not reveal what happened in proteins. The accumulated
alterations of DNAs would change the manifestation of proteins. Therefore, as is the case in …
alterations of DNAs would change the manifestation of proteins. Therefore, as is the case in …
Progress and prospects of early detection in lung cancer
S Blandin Knight, PA Crosbie, H Balata… - Open …, 2017 - royalsocietypublishing.org
Lung cancer is the leading cause of cancer-related death in the world. It is broadly divided
into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx …
into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx …
[HTML][HTML] Biomarkers in lung cancer screening: achievements, promises, and challenges
The present review is an update of the research and development efforts regarding the use
of molecular biomarkers in the lung cancer screening setting. The two main unmet clinical …
of molecular biomarkers in the lung cancer screening setting. The two main unmet clinical …
[HTML][HTML] British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
This guideline is based on a comprehensive review of the literature on pulmonary nodules
and expert opinion. Although the management pathway for the majority of nodules detected …
and expert opinion. Although the management pathway for the majority of nodules detected …
[HTML][HTML] Liquid biopsy for lung cancer: up-to-date and perspectives for screening programs
GMS Casagrande, MO Silva, RM Reis… - International Journal of …, 2023 - mdpi.com
Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study
Purpose Recent screening trial results indicate that low-dose computed tomography (LDCT)
reduces lung cancer mortality in high-risk patients. However, high false-positive rates, costs …
reduces lung cancer mortality in high-risk patients. However, high false-positive rates, costs …
[HTML][HTML] Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
Continuous revision of the histologic and stage-wise classification of lung cancer by the
World Health Organization (WHO) provides the foundation for therapeutic advances by …
World Health Organization (WHO) provides the foundation for therapeutic advances by …
[HTML][HTML] Advances in lung cancer screening and early detection
C Li, H Wang, Y Jiang, W Fu, X Liu… - Cancer biology & …, 2022 - ncbi.nlm.nih.gov
Lung cancer is associated with a heavy cancer-related burden in terms of patients' physical
and mental health worldwide. Two randomized controlled trials, the US-National Lung …
and mental health worldwide. Two randomized controlled trials, the US-National Lung …
[HTML][HTML] EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
CJ Chapman, GF Healey, A Murray, P Boyle… - Tumor Biology, 2012 - Springer
Tumor-associated autoantibodies (AAbs) have been described in patients with lung cancer,
and the Early CDT®-Lung test that measures such AAbs is available as an aid for the early …
and the Early CDT®-Lung test that measures such AAbs is available as an aid for the early …
Autoantibodies: opportunities for early cancer detection
Cancer cells can induce an immunological response resulting in the production of tumor-
associated (TA) autoantibodies. These serum immunobiomarkers have been detected for a …
associated (TA) autoantibodies. These serum immunobiomarkers have been detected for a …